Medical Reviews
Clinical applications of the results from the FOURIER open label extension study
As part of the REFLECTIONS - Dyslipidemia Global Newsletter #3, Prof. Lavalle Cobo (Argentina) discusses the article "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease".
Browse the full content of the Newsletter and access the written summary of the article by clicking on the link below: